Lyso-Globotriaosylceramide (d18:1)

Suppliers

Names

[ CAS No. ]:
126550-86-5

[ Name ]:
Lyso-Globotriaosylceramide (d18:1)

[Synonym ]:
(2S,3R,4E)-2-Amino-3-hydroxy-4-octadecen-1-yl α-D-galactopyranosyl-(1->4)-β-D-galactopyranosyl-(1->4)-β-D-glucopyranoside

Chemical & Physical Properties

[ Density]:
1.37g/cm3

[ Boiling Point ]:
1005.8ºC at 760 mmHg

[ Molecular Formula ]:
C36H67NO17

[ Molecular Weight ]:
785.91400

[ Flash Point ]:
562.1ºC

[ Exact Mass ]:
785.44100

[ PSA ]:
303.93000

[ Vapour Pressure ]:
0mmHg at 25°C

[ Index of Refraction ]:
1.591

MSDS

Click to get detail MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ RIDADR ]:
NONH for all modes of transport

Articles

LC–MS/MS analysis of plasma lyso-Gb3 in Fabry disease

Clin. Chim. Acta 414 , 273-80, (2012)

Background Fabry disease is a complex, multisystemic and clinically heterogeneous disease, with elevated excretion of globotriaosylceramide (Gb3) and globotriaosylsphingosine (lyso-Gb3) accumulating i...

A metabolomic study reveals novel plasma lyso-Gb3 analogs as Fabry disease biomarkers.

Curr. Med. Chem. 20(2) , 280-8, (2013)

Fabry disease is an X-linked, multisystemic lysosomal storage disorder due to alpha-galactosidase A deficiency. It is characterized by the accumulation of glycosphingolipids, mainly globotriaosylceram...

In vivo tumor targeting using a novel intestinal pathogen-based delivery approach.

Cancer Res. 66(14) , 7230-6, (2006)

Efficient methods for tumor targeting are eagerly awaited and must satisfy several challenges: molecular specificity, transport through physiologic barriers, and capacity to withstand extracellular or...


More Articles

Related Compounds

  • C16 Globotriaosylceramide (d18:1/16:0)
  • C18 Globotriaosylceramide (d18:1/18:0)
  • C23 Globotriaosylceramide (d18:1/23:0)
  • C17 Globotriaosylceramide (d18:1/17:0)
  • C2 Adamantanyl Globotriaosylceramide (d18:1/2:0)
  • Lyso-PAF C-16-d4
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • [2-[6-(3-Chlorophenyl)-4-methylpyridin-3-yl]-4-hydroxypyrrolidin-1-yl]-pyrazin-2-ylmethanone
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide